These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25155494)

  • 21. Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports.
    Kamar N; Faguer S; Esposito L; Guitard J; Nogier MB; Durand D; Rostaing L
    Clin Nephrol; 2007 Apr; 67(4):250-4. PubMed ID: 17474562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
    Ravani P; Ponticelli A; Siciliano C; Fornoni A; Magnasco A; Sica F; Bodria M; Caridi G; Wei C; Belingheri M; Ghio L; Merscher-Gomez S; Edefonti A; Pasini A; Montini G; Murtas C; Wang X; Muruve D; Vaglio A; Martorana D; Pani A; Scolari F; Reiser J; Ghiggeri GM
    Kidney Int; 2013 Nov; 84(5):1025-33. PubMed ID: 23739238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.
    Ruggenenti P; Ruggiero B; Cravedi P; Vivarelli M; Massella L; Marasà M; Chianca A; Rubis N; Ene-Iordache B; Rudnicki M; Pollastro RM; Capasso G; Pisani A; Pennesi M; Emma F; Remuzzi G;
    J Am Soc Nephrol; 2014 Apr; 25(4):850-63. PubMed ID: 24480824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protracted remission of proteinuria after combined therapy with plasmapheresis and anti-CD20 antibodies/cyclophosphamide in a child with oligoclonal IgM and glomerulosclerosis.
    Ghiggeri GM; Musante L; Candiano G; Bruschi M; Santucci L; Barbano G; Trivelli A; Rivabella L; Gusmano R; Perfumo F
    Pediatr Nephrol; 2007 Nov; 22(11):1953-6. PubMed ID: 17661091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete remission of tip lesion variant focal segmental glomerulosclerosis (FSGS) with the Janus Kinase (JAK) inhibitor tofacitinib.
    Sedlacek M; Pettus JR
    CEN Case Rep; 2022 May; 11(2):225-230. PubMed ID: 34741283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab for refractory cases of childhood nephrotic syndrome.
    Kari JA; El-Morshedy SM; El-Desoky S; Alshaya HO; Rahim KA; Edrees BM
    Pediatr Nephrol; 2011 May; 26(5):733-7. PubMed ID: 21279725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete remission of nephrotic syndrome in an infant with focal segmental glomerulosclerosis: is it renin-angiotensin blockade?
    Soliman NA; Francis M; Heeringa SF; Chernin G
    Pediatr Nephrol; 2009 May; 24(5):1065-70. PubMed ID: 18853198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.
    Hogan J; Bomback AS; Mehta K; Canetta PA; Rao MK; Appel GB; Radhakrishnan J; Lafayette RA
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2072-81. PubMed ID: 24009220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephrotic syndrome with focal segmental glomerulosclerosis after an insect bite.
    Révai T; Kaszás I; Márton C; Arpási G; Winkler G
    Clin Nephrol; 2006 Aug; 66(2):128-30. PubMed ID: 16939069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis.
    Heering P; Braun N; Müllejans R; Ivens K; Zäuner I; Fünfstück R; Keller F; Krämer BK; Schollmeyer P; Risler T; Grabensee B;
    Am J Kidney Dis; 2004 Jan; 43(1):10-8. PubMed ID: 14712422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Our experience with rituximab therapy for adult-onset primary glomerulonephritis and review of literature.
    Kong WY; Swaminathan R; Irish A
    Int Urol Nephrol; 2013 Jun; 45(3):795-802. PubMed ID: 22798030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis.
    Yabu JM; Ho B; Scandling JD; Vincenti F
    Am J Transplant; 2008 Jan; 8(1):222-7. PubMed ID: 17979998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Advances in Treatments of Primary Focal Segmental Glomerulosclerosis in Children.
    Han KH; Kim SH
    Biomed Res Int; 2016; 2016():3053706. PubMed ID: 27195285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [No effect of rituximab in pediatric case of severe nephrotic syndrome and focal segmental glomeruloslerosis accompanied by renal insufficiency].
    Hyla-Klekot L; Grenda R; Pulcer B
    Pol Merkur Lekarski; 2008 Dec; 25(150):519-22. PubMed ID: 19205386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
    Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
    Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin.
    Kaito H; Kamei K; Kikuchi E; Ogura M; Matsuoka K; Nagata M; Iijima K; Ito S
    Pediatr Nephrol; 2010 May; 25(5):957-9. PubMed ID: 20033219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab and low-dose cyclosporine combination therapy for steroid-resistant focal segmental glomerulosclerosis.
    Suyama K; Kawasaki Y; Miyazaki K; Kanno S; Ono A; Suzuki Y; Ohara S; Hosoya M
    Pediatr Int; 2016 Mar; 58(3):219-223. PubMed ID: 26275234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab therapy in nephrotic syndrome: implications for patients' management.
    Sinha A; Bagga A
    Nat Rev Nephrol; 2013 Mar; 9(3):154-69. PubMed ID: 23338210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis.
    Siligato R; Cernaro V; Nardi C; De Gregorio F; Gembillo G; Costantino G; Conti G; Buemi M; Santoro D
    Expert Opin Investig Drugs; 2018 Nov; 27(11):839-879. PubMed ID: 30360670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.